S Jalkanen

1.3k citations
16 papers · 1.0k indexed · h-index 10
Topics
Glycosylation and Glycoproteins Research (7 papers)Cell Adhesion Molecules Research (5 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)

In The Last Decade

S Jalkanen

16 papers receiving 990 citations

Peers

S Jalkanen
Comparison fields: 5 of 73
  • Molecular Biology 465
  • Cell Biology 420
  • Immunology and Allergy 336
  • Immunology 267
  • Oncology 154
Replace Taneli Tani with:
Taneli Tani Finland
Rosemarie Dalchau United Kingdom
J. Bamat Switzerland
Robert M. J. Keehnen Netherlands
Takaaki Hato Japan
Diane R. Leone United States
David Zhou United States
G N van Muijen Netherlands
Samuel Godár Austria
Pascale Jackers Belgium
S Jalkanen relative to Taneli Tani Finland Taneli Tani's profile →
Citations per field
00.5×3.1×
Taneli Tani · 1×
Citations per year

Countries citing papers authored by S Jalkanen

Since Specialization
Citations

This map shows the geographic impact of S Jalkanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Jalkanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Jalkanen more than expected).

Fields of papers citing papers by S Jalkanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Jalkanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Jalkanen. The network helps show where S Jalkanen may publish in the future.

Co-authorship network of co-authors of S Jalkanen

This figure shows the co-authorship network connecting the top 25 collaborators of S Jalkanen. A scholar is included among the top collaborators of S Jalkanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Jalkanen. S Jalkanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 5
2 70
3 4
4 9
5 8
6 26
7 20
8
Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells.
61
9 90
10 91
11 6
12 121
13 450
14 4
15 52
16 3

About S Jalkanen

S Jalkanen is a scholar working on Immunology and Allergy, Immunology and Cell Biology, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (7 papers), Cell Adhesion Molecules Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Immunology and Allergy (336 citations), Cell Biology (420 citations) and Immunology (267 citations). S Jalkanen has collaborated with scholars based in Finland, United States and Portugal. Frequent co-authors include Markku Jalkanen, Marko Salmi, David P. Andrew, Eugene C. Butcher, Heikki Joensuu, P. Klemi, Stefan G. Hübscher, David Adams, Gillian McNab and Kaisa Granfors. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026